Clinical Trial Update: Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing varenicline to placebo for smoking cessation in individuals with schizophrenia; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cigarette Smoking
• Schizophrenia

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Cigarette Smoking, Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2017-05-15